2019 annual financial data
INmune Bio 2019 Operating cash flow margin
Direct answer
Operating cash flow margin was -6.93%.
Operating income was -7,756,001 USD and net income was -7,678,313 USD.
Operating cash flow was -5,384,656 USD.
Get free INmune Bio email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 77,688,000 USD
- Operating income
- -7,756,001 USD
- Net income
- -7,678,313 USD
- Operating cash flow
- -5,384,656 USD